Skip to main content

Primary Cutaneous Melanocytic Neoplasms

  • Reference work entry
  • First Online:
Melanoma
  • 855 Accesses

Abstract

This chapter on primary cutaneous melanocytic neoplasms of the skin will discuss three major categories of benign melanocytic neoplasms: common acquired, congenital, and blue nevi. The predominant initiating genomic event in common acquired nevi is a mutation in BRAF, while a significantly smaller percentage have a mutation in NRAS. Mutations in NRAS occur far more frequently in congenital nevi; the ratio of NRAS to BRAF mutations in congenital nevi varies depending on the size of the congenital nevus. Giant congenital nevi are almost exclusively NRAS mutated. Blue nevi commonly have mutations in GNAQ and GNA11 and likely have a distinct melanocytic precursor cell compared to many, but not all, common acquired nevi. This chapter will highlight how specific mutations and melanocytic precursor cell types impact morphology of benign melanocytic nevi and how these factors can be integrated into a more reproducible classification system. The author also discusses two major subtypes of melanoma: those occurring on non-chronically sun-damaged skin, which have frequent BRAF mutations, and melanomas occurring in chronically sun-damaged skin, which have less frequent BRAF and NRAS mutations but have occasional mutations in c-Kit or NF1. Likewise, the author discusses how the mutation and cell of origin in these melanomas relate to morphology and ultimately can be used for a more robust classification system.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 799.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 549.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Aalborg J, Morelli JG, Mokrohisky ST, Asdigian NL, Byers TE, Dellavalle RP, Box NF, Crane LA (2009) Tanning and increased nevus development in very-light-skinned children without red hair. Arch Dermatol 145(9):989–996

    Article  PubMed  PubMed Central  Google Scholar 

  • Aalto Y, Eriksson L, Seregard S, Larsson O, Knuutila S (2001) Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma. Invest Ophthalmol Vis Sci 42(2):313–317

    CAS  PubMed  Google Scholar 

  • Alikhan A, Ibrahimi OA, Eisen DB (2012) Congenital melanocytic nevi: where are we now? Part I. Clinical presentation, epidemiology, pathogenesis, histology, malignant transformation, and neurocutaneous melanosis. J Am Acad Dermatol 67(4):495–511

    Article  PubMed  Google Scholar 

  • Azzola MF, Shaw HM, Thompson JF, Soong SJ, Scolyer RA, Watson GF, Colman MH, Zhang Y (2003) Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center. Cancer 97(6):1488–1498. https://doi.org/10.1002/cncr.11196

    Article  PubMed  Google Scholar 

  • Ball NJ, Golitz LE (1994) Melanocytic nevi with focal atypical epithelioid cell components: a review of seventy-three cases. J Am Acad Dermatol 30(5 Pt 1):724–729

    Article  CAS  PubMed  Google Scholar 

  • Bastian BC (2014) The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia. Annu Rev Pathol 9:239–271. https://doi.org/10.1146/annurev-pathol-012513-104658

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bastian BC, Kashani-Sabet M, Hamm H, Godfrey T, Moore DH 2nd, Brocker EB, LeBoit PE, Pinkel D (2000) Gene amplifications characterize acral melanoma and permit the detection of occult tumor cells in the surrounding skin. Cancer Res 60(7):1968–1973

    CAS  PubMed  Google Scholar 

  • Bastian BC, Xiong J, Frieden IJ, Williams ML, Chou P, Busam K, Pinkel D, LeBoit PE (2002) Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas. Am J Pathol 161(4):1163–1169. https://doi.org/10.1016/S0002-9440(10)64393-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bauer J, Curtin JA, Pinkel D, Bastian BC (2007) Congenital melanocytic nevi frequently harbor NRAS mutations but no BRAF mutations. J Invest Dermatol 127(1):179–182

    Article  CAS  PubMed  Google Scholar 

  • Bett BJ (2005) Large or multiple congenital melanocytic nevi: occurrence of cutaneous melanoma in 1008 persons. J Am Acad Dermatol 52(5):793–797

    Article  PubMed  Google Scholar 

  • Betti R, Martino P, Vergani R, Gualandri L, Crosti C (2008) Nodular melanomas: analysis of the casistic and relationship with thick melanomas and diagnostic delay. J Dermatol 35(10):643–650. https://doi.org/10.1111/j.1346-8138.2008.00536.x

    Article  PubMed  Google Scholar 

  • Broekaert SM, Roy R, Okamoto I, van den Oord J, Bauer J, Garbe C, Barnhill RL, Busam KJ, Cochran AJ, Cook MG, Elder DE, McCarthy SW, Mihm MC, Schadendorf D, Scolyer RA, Spatz A, Bastian BC (2010) Genetic and morphologic features for melanoma classification. Pigment Cell Melanoma Res 23(6):763–770. https://doi.org/10.1111/j.1755-148X.2010.00778.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cancer Genome Atlas N (2015) Genomic classification of cutaneous melanoma. Cell 161(7):1681–1696

    Article  CAS  Google Scholar 

  • Castilla EE, da Graca Dutra M, Orioli-Parreiras IM (1981) Epidemiology of congenital pigmented naevi: I. Incidence rates and relative frequencies. Br J Dermatol 104(3):307–315

    Article  CAS  PubMed  Google Scholar 

  • Connelly J, Smith JL Jr (1991) Malignant blue nevus. Cancer 67(10):2653–2657

    Article  CAS  PubMed  Google Scholar 

  • Cook MG, Clarke TJ, Humphreys S, Fletcher A, McLaren KM, Smith NP, Stevens A, Theaker JM, Melia J (1996) The evaluation of diagnostic and prognostic criteria and the terminology of thin cutaneous malignant melanoma by the CRC melanoma pathology panel. Histopathology 28(6):497–512

    Article  CAS  PubMed  Google Scholar 

  • Costa S, Byrne M, Pissaloux D, Haddad V, Paindavoine S, Thomas L, Aubin F, Lesimple T, Grange F, Bonniaud B, Mortier L, Mateus C, Dreno B, Balme B, Vergier B, de la Fouchardiere A (2016) Melanomas associated with blue nevi or mimicking cellular blue nevi: clinical, pathologic, and molecular study of 11 cases displaying a high frequency of GNA11 mutations, BAP1 expression loss, and a predilection for the scalp. Am J Surg Pathol 40(3):368–377

    Article  PubMed  Google Scholar 

  • Curtin JA, Busam K, Pinkel D, Bastian BC (2006) Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 24(26):4340–4346

    Article  CAS  PubMed  Google Scholar 

  • Dankort D, Curley DP, Cartlidge RA, Nelson B, Karnezis AN, Damsky WE Jr, You MJ, DePinho RA, McMahon M, Bosenberg M (2009) Braf(V600E) cooperates with Pten loss to induce metastatic melanoma. Nat Genet 41(5):544–552

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • DeDavid M, Orlow SJ, Provost N, Marghoob AA, Rao BK, Wasti Q, Huang CL, Kopf AW, Bart RS (1996) Neurocutaneous melanosis: clinical features of large congenital melanocytic nevi in patients with manifest central nervous system melanosis. J Am Acad Dermatol 35(4):529–538

    Article  CAS  PubMed  Google Scholar 

  • Dulon M, Weichenthal M, Blettner M, Breitbart M, Hetzer M, Greinert R, Baumgardt-Elms C, Breitbart EW (2002) Sun exposure and number of nevi in 5- to 6-year-old European children. J Clin Epidemiol 55(11):1075–1081

    Article  PubMed  Google Scholar 

  • Ellerhorst JA, Greene VR, Ekmekcioglu S, Warneke CL, Johnson MM, Cooke CP, Wang LE, Prieto VG, Gershenwald JE, Wei Q, Grimm EA (2011) Clinical correlates of NRAS and BRAF mutations in primary human melanoma. Clin Cancer Res 17(2):229–235

    Article  CAS  PubMed  Google Scholar 

  • Fernandes KJ, McKenzie IA, Mill P, Smith KM, Akhavan M, Barnabe-Heider F, Biernaskie J, Junek A, Kobayashi NR, Toma JG, Kaplan DR, Labosky PA, Rafuse V, Hui CC, Miller FD (2004) A dermal niche for multipotent adult skin-derived precursor cells. Nat Cell Biol 6(11):1082–1093

    Article  CAS  PubMed  Google Scholar 

  • Elder DE (2016) Melanoma progression. Pathology 48(2):147–154

    Article  PubMed  Google Scholar 

  • Francken AB, Shaw HM, Thompson JF, Soong SJ, Accortt NA, Azzola MF, Scolyer RA, Milton GW, McCarthy WH, Colman MH, McGovern VJ (2004) The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up. Ann Surg Oncol 11(4):426–433. https://doi.org/10.1245/ASO.2004.07.014

    Article  PubMed  Google Scholar 

  • George E, McClain SE, Slingluff CL, Polissar NL, Patterson JW (2009) Subclassification of desmoplastic melanoma: pure and mixed variants have significantly different capacities for lymph node metastasis. J Cutan Pathol 36(4):425–432

    Article  PubMed  Google Scholar 

  • Gerami P, Cook RW, Russell MC, Wilkinson J, Amaria RN, Gonzalez R, Lyle S, Jackson GL, Greisinger AJ, Johnson CE, Oelschlager KM, Stone JF, Maetzold DJ, Ferris LK, Wayne JD, Cooper C, Obregon R, Delman KA, Lawson D (2015a) Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy. J Am Acad Dermatol 72(5):780–785. e783. https://doi.org/10.1016/j.jaad.2015.01.009

    Article  CAS  PubMed  Google Scholar 

  • Gerami P, Cook RW, Wilkinson J, Russell MC, Dhillon N, Amaria RN, Gonzalez R, Lyle S, Johnson CE, Oelschlager KM, Jackson GL, Greisinger AJ, Maetzold D, Delman KA, Lawson DH, Stone JF (2015b) Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma. Clin Cancer Res 21(1):175–183. https://doi.org/10.1158/1078-0432.CCR-13-3316

    Article  CAS  PubMed  Google Scholar 

  • Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, Lazar AJ, Faries MB, Kirkwood JM, McArthur GA, Haydu LE, Eggermont AMM, Flaherty KT, Balch CM, Thompson JF, for members of the American Joint Committee on Cancer Melanoma Expert Panel and the International Melanoma Database and Discovery Platform (2017) Melanoma staging: evidence-based changes in the American joint committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 67(6):472–492. https://doi.org/10.3322/caac.21409

    Article  PubMed  PubMed Central  Google Scholar 

  • Goldgar DE, Cannon-Albright LA, Meyer LJ, Piepkorn MW, Zone JJ, Skolnick MH (1991) Inheritance of nevus number and size in melanoma and dysplastic nevus syndrome kindreds. J Natl Cancer Inst 83(23):1726–1733

    Article  CAS  PubMed  Google Scholar 

  • Gutzmer R, Herbst RA, Mommert S, Kiehl P, Matiaske F, Rutten A, Kapp A, Weiss J (2000) Allelic loss at the neurofibromatosis type 1 (NF1) gene locus is frequent in desmoplastic neurotropic melanoma. Hum Genet 107(4):357–361

    Article  CAS  PubMed  Google Scholar 

  • Gyorki DE, Busam K, Panageas K, Brady MS, Coit DG (2003) Sentinel lymph node biopsy for patients with cutaneous desmoplastic melanoma. Ann Surg Oncol 10(4):403–407

    Article  PubMed  Google Scholar 

  • Harbour JW, Chao DL (2014) A molecular revolution in uveal melanoma: implications for patient care and targeted therapy. Ophthalmology 121(6):1281–1288

    Article  PubMed  Google Scholar 

  • Harbour JW, Onken MD, Roberson ED, Duan S, Cao L, Worley LA, Council ML, Matatall KA, Helms C, Bowcock AM (2010) Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 330(6009):1410–1413

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Haugh AM, Zhang B, Quan VL, Garfield EM, Bubley JA, Kudalkar E, Verzi AE, Walton K, VandenBoom T, Merkel EA, Lee CY, Tan T, Isales MC, Kong BY, Wenzel AT, Bunick CG, Choi J, Sosman J, Gerami P (2018) Distinct patterns of Acral melanoma based on site and relative sun exposure. J Invest Dermatol 138(2):384–393. https://doi.org/10.1016/j.jid.2017.08.022

    Article  CAS  PubMed  Google Scholar 

  • Heenan PJ, Matz LR, Blackwell JB, Kelsall GR, Singh A, ten Seldam RE, Holman CD (1984) Inter-observer variation between pathologists in the classification of cutaneous malignant melanoma in western Australia. Histopathology 8(5):717–729

    Article  CAS  PubMed  Google Scholar 

  • Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA (2013) Highly recurrent TERT promoter mutations in human melanoma. Science 339(6122):957–959

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hussein MR, Wood GS (2002) Molecular aspects of melanocytic dysplastic nevi. J Mol Diagn 4(2):71–80. https://doi.org/10.1016/S1525-1578(10)60684-8

    Article  PubMed  PubMed Central  Google Scholar 

  • Ichii-Nakato N, Takata M, Takayanagi S, Takashima S, Lin J, Murata H, Fujimoto A, Hatta N, Saida T (2006) High frequency of BRAFV600E mutation in acquired nevi and small congenital nevi, but low frequency of mutation in medium-sized congenital nevi. J Invest Dermatol 126(9):2111–2118

    Article  CAS  PubMed  Google Scholar 

  • Illig L, Weidner F, Hundeiker M, Gartmann H, Biess B, Leyh F, Paul E (1985) Congenital nevi less than or equal to 10 cm as precursors to melanoma. 52 cases, a review, and a new conception. Arch Dermatol 121(10):1274–1281

    Article  CAS  PubMed  Google Scholar 

  • Kinsler VA, Chong WK, Aylett SE, Atherton DJ (2008) Complications of congenital melanocytic naevi in children: analysis of 16 years’ experience and clinical practice. Br J Dermatol 159(4):907–914

    Article  CAS  PubMed  Google Scholar 

  • Kinsler VA, Thomas AC, Ishida M, Bulstrode NW, Loughlin S, Hing S, Chalker J, McKenzie K, Abu-Amero S, Slater O, Chanudet E, Palmer R, Morrogh D, Stanier P, Healy E, Sebire NJ, Moore GE (2013) Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS. J Invest Dermatol 133(9):2229–2236

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Landi MT, Bauer J, Pfeiffer RM, Elder DE, Hulley B, Minghetti P, Calista D, Kanetsky PA, Pinkel D, Bastian BC (2006) MC1R germline variants confer risk for BRAF-mutant melanoma. Science 313(5786):521–522

    Article  CAS  PubMed  Google Scholar 

  • Landow SM, Gjelsvik A, Weinstock MA (2017) Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992-2013. J Am Acad Dermatol 76(2):258–263. https://doi.org/10.1016/j.jaad.2016.10.018

    Article  PubMed  Google Scholar 

  • Larsen TE, Little JH, Orell SR, Prade M (1980) International pathologists congruence survey on quantitation of malignant melanoma. Pathology 12(2):245–253

    Article  CAS  PubMed  Google Scholar 

  • Lee S, Duffy DL, McClenahan P, Lee KJ, McEniery E, Burke B, Jagirdar K, Martin NG, Sturm RA, Soyer HP, Schaider H (2016) Heritability of naevus patterns in an adult twin cohort from the Brisbane twin registry: a cross-sectional study. Br J Dermatol 174(2):356–363

    Article  CAS  PubMed  Google Scholar 

  • Lee JH, Choi JW, Kim YS (2011) Frequencies of BRAF and NRAS mutations are different in histological types and sites of origin of cutaneous melanoma: a meta-analysis. Br J Dermatol 164(4):776–784. https://doi.org/10.1111/j.1365-2133.2010.10185.x

    Article  CAS  PubMed  Google Scholar 

  • Liu W, McArthur GA, Trivett M, Murray WK, Wolfe R, Kelly JW (2008) Correlation of subjective self-reported melanoma growth rate with objective tumor proliferation markers. Arch Dermatol 144(4):555–556. https://doi.org/10.1001/archderm.144.4.555

    Article  PubMed  Google Scholar 

  • Maldonado JL, Fridlyand J, Patel H, Jain AN, Busam K, Kageshita T, Ono T, Albertson DG, Pinkel D, Bastian BC (2003) Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 95(24):1878–1890

    Article  CAS  PubMed  Google Scholar 

  • Mar V, Roberts H, Wolfe R, English DR, Kelly JW (2013) Nodular melanoma: a distinct clinical entity and the largest contributor to melanoma deaths in Victoria, Australia. J Am Acad Dermatol 68(4):568–575. https://doi.org/10.1016/j.jaad.2012.09.047

    Article  PubMed  Google Scholar 

  • Marghoob AA, Dusza S, Oliveria S, Halpern AC (2004) Number of satellite nevi as a correlate for neurocutaneous melanocytosis in patients with large congenital melanocytic nevi. Arch Dermatol 140(2):171–175

    Article  PubMed  Google Scholar 

  • Marks R, Dorevitch AP, Mason G (1990) Do all melanomas come from “moles”? A study of the histological association between melanocytic naevi and melanoma. Australas J Dermatol 31(2):77–80

    Article  CAS  PubMed  Google Scholar 

  • Moon KR, Choi YD, Kim JM, Jin S, Shin MH, Shim HJ, Lee JB, Yun SJ (2018) Genetic Alterations in Primary Acral Melanoma and Acral Melanocytic Nevus in Korea: Common Mutated Genes Show Distinct Cytomorphological Features. J Invest Dermatol 138(4):933–945. https://doi.org/10.1016/j.jid.2017.11.017

    Article  CAS  Google Scholar 

  • Nguyen LP, Emley A, Wajapeyee N, Green MR, Mahalingam M (2010) BRAF V600E mutation and the tumour suppressor IGFBP7 in atypical genital naevi. Br J Dermatol 162(3):677–680

    Article  CAS  PubMed  Google Scholar 

  • Oliveria SA, Yagerman SE, Jaimes N, Goodwin AI, Dusza SW, Halpern AC, Marghoob AA (2013) Clinical and dermoscopic characteristics of new naevi in adults: results from a cohort study. Br J Dermatol 169(4):848–853

    Article  CAS  PubMed  Google Scholar 

  • Pan Y, Adler NR, Wolfe R, McLean CA, Kelly JW (2017) Nodular melanoma is less likely than superficial spreading melanoma to be histologically associated with a naevus. Med J Aust 207(8):333–338

    Article  PubMed  Google Scholar 

  • Pawlik TM, Ross MI, Prieto VG, Ballo MT, Johnson MM, Mansfield PF, Lee JE, Cormier JN, Gershenwald JE (2006) Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma. Cancer 106(4):900–906

    Article  PubMed  Google Scholar 

  • Phadke PA, Rakheja D, Le LP, Selim MA, Kapur P, Davis A, Mihm MC Jr, Hoang MP (2011) Proliferative nodules arising within congenital melanocytic nevi: a histologic, immunohistochemical, and molecular analyses of 43 cases. Am J Surg Pathol 35(5):656–669

    Article  PubMed  Google Scholar 

  • Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, Moses TY, Hostetter G, Wagner U, Kakareka J, Salem G, Pohida T, Heenan P, Duray P, Kallioniemi O, Hayward NK, Trent JM, Meltzer PS (2003) High frequency of BRAF mutations in nevi. Nat Genet 33(1):19–20

    Article  CAS  PubMed  Google Scholar 

  • Pouryazdanparast P, Brenner A, Haghighat Z, Guitart J, Rademaker A, Gerami P (2012a) The role of 8q24 copy number gains and c-MYC expression in amelanotic cutaneous melanoma. Mod Pathol 25(9):1221–1226

    Article  CAS  PubMed  Google Scholar 

  • Pouryazdanparast P, Cowen DP, Beilfuss BA, Haghighat Z, Guitart J, Rademaker A, Gerami P (2012b) Distinctive clinical and histologic features in cutaneous melanoma with copy number gains in 8q24. Am J Surg Pathol 36(2):253–264

    Article  PubMed  Google Scholar 

  • Rhodes AR, Albert LS, Weinstock MA (1996) Congenital nevomelanocytic nevi: proportionate area expansion during infancy and early childhood. J Am Acad Dermatol 34(1):51–62

    Article  CAS  PubMed  Google Scholar 

  • Rigel DS, Friedman RJ, Kopf AW, Polsky D (2005) ABCDE–an evolving concept in the early detection of melanoma. Arch Dermatol 141(8):1032–1034

    Article  PubMed  Google Scholar 

  • Ruiz-Maldonado R, Tamayo L, Laterza AM, Duran C (1992) Giant pigmented nevi: clinical, histopathologic, and therapeutic considerations. J Pediatr 120(6):906–911

    Article  CAS  PubMed  Google Scholar 

  • Scalzo DA, Hida CA, Toth G, Sober AJ, Mihm MC Jr (1997) Childhood melanoma: a clinicopathological study of 22 cases. Melanoma Res 7(1):63–68

    Article  CAS  PubMed  Google Scholar 

  • Shaikh WR, Dusza SW, Weinstock MA, Oliveria SA, Geller AC, Halpern AC (2016) Melanoma thickness and survival trends in the United States, 1989 to 2009. J Natl Cancer Inst 108(1). https://doi.org/10.1093/jnci/djv294

  • Shain AH, Yeh I, Kovalyshyn I, Sriharan A, Talevich E, Gagnon A, Dummer R, North J, Pincus L, Ruben B, Rickaby W, D'Arrigo C, Robson A, Bastian BC (2015) The genetic evolution of melanoma from precursor lesions. N Engl J Med 373(20):1926–1936

    Article  PubMed  CAS  Google Scholar 

  • Shors AR, Kim S, White E, Argenyi Z, Barnhill RL, Duray P, Erickson L, Guitart J, Horenstein MG, Lowe L, Messina J, Rabkin MS, Schmidt B, Shea CR, Trotter MJ, Piepkorn MW (2006) Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma. Br J Dermatol 155(5):988–993. https://doi.org/10.1111/j.1365-2133.2006.07466.x

    Article  CAS  PubMed  Google Scholar 

  • Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66(1):7–30

    Article  PubMed  Google Scholar 

  • Singh P, Kim HJ, Schwartz RA (2016) Superficial spreading melanoma: an analysis of 97 702 cases using the SEER database. Melanoma Res 26(4):395–400. https://doi.org/10.1097/CMR.0000000000000245

    Article  PubMed  Google Scholar 

  • Swerdlow AJ, English JS, Qiao Z (1995) The risk of melanoma in patients with congenital nevi: a cohort study. J Am Acad Dermatol 32(4):595–599

    Article  CAS  PubMed  Google Scholar 

  • Thomas NE, Edmiston SN, Alexander A, Millikan RC, Groben PA, Hao H, Tolbert D, Berwick M, Busam K, Begg CB, Mattingly D, Ollila DW, Tse CK, Hummer A, Lee-Taylor J, Conway K (2007) Number of nevi and early-life ambient UV exposure are associated with BRAF-mutant melanoma. Cancer Epidemiol Biomark Prev 16(5):991–997

    Article  CAS  Google Scholar 

  • Thompson JF, Soong SJ, Balch CM, Gershenwald JE, Ding S, Coit DG, Flaherty KT, Gimotty PA, Johnson T, Johnson MM, Leong SP, Ross MI, Byrd DR, Cascinelli N, Cochran AJ, Eggermont AM, McMasters KM, Mihm MC Jr, Morton DL, Sondak VK (2011) Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American joint committee on Cancer melanoma staging database. J Clin Oncol 29(16):2199–2205. https://doi.org/10.1200/JCO.2010.31.5812

    Article  PubMed  PubMed Central  Google Scholar 

  • Tsao H, Bevona C, Goggins W, Quinn T (2003) The transformation rate of moles (melanocytic nevi) into cutaneous melanoma: a population-based estimate. Arch Dermatol 139(3):282–288

    Article  PubMed  Google Scholar 

  • Tsao H, Goel V, Wu H, Yang G, Haluska FG (2004) Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma. J Invest Dermatol 122(2):337–341. https://doi.org/10.1046/j.0022-202X.2004.22243.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tucker MA, Fraser MC, Goldstein AM, Struewing JP, King MA, Crawford JT, Chiazze EA, Zametkin DP, Fontaine LS, Clark WH Jr (2002) A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families. Cancer 94(12):3192–3209

    Article  PubMed  Google Scholar 

  • Tucker MA, Halpern A, Holly EA, Hartge P, Elder DE, Sagebiel RW, Guerry D t, Clark WH Jr (1997) Clinically recognized dysplastic nevi. A central risk factor for cutaneous melanoma. JAMA 277(18):1439–1444

    Article  CAS  PubMed  Google Scholar 

  • Unna PG (1893) Nevi and nevocarcinome. Berl Klin Wochenschr 30:14–16

    Google Scholar 

  • Van Raamsdonk CD, Bezrookove V, Green G, Bauer J, Gaugler L, O'Brien JM, Simpson EM, Barsh GS, Bastian BC (2009) Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 457(7229):599–602

    Article  PubMed  CAS  Google Scholar 

  • Van Raamsdonk CD, Fitch KR, Fuchs H, de Angelis MH, Barsh GS (2004) Effects of G-protein mutations on skin color. Nat Genet 36(9):961–968

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Van Raamsdonk CD, Griewank KG, Crosby MB, Garrido MC, Vemula S, Wiesner T, Obenauf AC, Wackernagel W, Green G, Bouvier N, Sozen MM, Baimukanova G, Roy R, Heguy A, Dolgalev I, Khanin R, Busam K, Speicher MR, O'Brien J, Bastian BC (2010) Mutations in GNA11 in uveal melanoma. N Engl J Med 363(23):2191–2199

    Article  PubMed  PubMed Central  Google Scholar 

  • Verzi AE, Quan VL, Walton KE, Martini MC, Marghoob AA, Garfield EM, Kong BY, Isales MC, VandenBoom T, Zhang B, West DP, Gerami P (2018) The diagnostic value and histologic correlate of distinct patterns of shiny white streaks for the diagnosis of melanoma: A retrospective, case-control study. J Am Acad Dermatol 78(5):913–919. https://doi.org/10.1016/j.jaad.2017.11.021. PMID: 29138058

    Article  PubMed  Google Scholar 

  • Viros A, Fridlyand J, Bauer J, Lasithiotakis K, Garbe C, Pinkel D, Bastian BC (2008) Improving melanoma classification by integrating genetic and morphologic features. PLoS Med 5(6):e120. https://doi.org/10.1371/journal.pmed.0050120

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wachsmuth RC, Gaut RM, Barrett JH, Saunders CL, Randerson-Moor JA, Eldridge A, Martin NG, Bishop TD, Newton Bishop JA (2001) Heritability and gene-environment interactions for melanocytic nevus density examined in a U.K. adolescent twin study. J Invest Dermatol 117(2):348–352

    Article  CAS  PubMed  Google Scholar 

  • Whiteman DC, Baade PD, Olsen CM (2015) More people die from thin melanomas (1 mm) than from thick melanomas (>4 mm) in Queensland, Australia. J Invest Dermatol 135(4):1190–1193. https://doi.org/10.1038/jid.2014.452

    Article  CAS  PubMed  Google Scholar 

  • Wiecker TS, Luther H, Buettner P, Bauer J, Garbe C (2003) Moderate sun exposure and nevus counts in parents are associated with development of melanocytic nevi in childhood: a risk factor study in 1,812 kindergarten children. Cancer 97(3):628–638

    Article  PubMed  CAS  Google Scholar 

  • Yelamos O, Arva NC, Obregon R, Yazdan P, Wagner A, Guitart J, Gerami P (2015a) A comparative study of proliferative nodules and lethal melanomas in congenital nevi from children. Am J Surg Pathol 39(3):405–415

    Article  PubMed  Google Scholar 

  • Yelamos O, Busam KJ, Lee C, Meldi Sholl L, Amin SM, Merkel EA, Obregon R, Guitart J, Gerami P (2015b) Morphologic clues and utility of fluorescence in situ hybridization for the diagnosis of nevoid melanoma. J Cutan Pathol 42(11):796–806

    Article  PubMed  Google Scholar 

  • Yelamos O, Merkel EA, Sholl LM, Zhang B, Amin SM, Lee CY, Guitart GE, Yang J, Wenzel AT, Bunick CG, Yazdan P, Choi J, Gerami P (2016) Non-overlapping clinical and mutational patterns in melanomas from the female genital tract and atypical genital nevi. J Invest Dermatol 136(9):1858–1865

    Article  CAS  Google Scholar 

  • Zager JS, Gastman BR, Leachman S, Gonzalez RC, Fleming MD, Ferris LK, Ho J, Miller AR, Cook RW, Covington KR, Meldi-Plasseraud K, Middlebrook B, Kaminester LH, Greisinger A, Estrada SI, Pariser DM, Cranmer LD, Messina JL, Vetto JT, Wayne JD, Delman KA, Lawson DH, Gerami P (2018) Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients. BMC Cancer 18(1):130. https://doi.org/10.1186/s12885-018-4016-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pedram Gerami .

Editor information

Editors and Affiliations

Section Editor information

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Science+Business Media, LLC, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Gerami, P. (2019). Primary Cutaneous Melanocytic Neoplasms. In: Fisher, D., Bastian, B. (eds) Melanoma. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7147-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-7147-9_1

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-7148-6

  • Online ISBN: 978-1-4614-7147-9

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics